These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15222701)

  • 1. Multiple sclerosis following treatment with a cannabinoid receptor-1 antagonist.
    van Oosten BW; Killestein J; Mathus-Vliegen EM; Polman CH
    Mult Scler; 2004 Jun; 10(3):330-1. PubMed ID: 15222701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of rimonabant on weight reduction and cardiovascular risk.
    van Oosten B; Killestein J; Polman Ch
    Lancet; 2005 Jul 30-Aug 5; 366(9483):368-9; author reply 369-70. PubMed ID: 16054933
    [No Abstract]   [Full Text] [Related]  

  • 3. Antagonism of type-1 cannabinoid receptors: good for obesity, but is it safe for fertility?
    Maccarrone M; Wang H; Dey SK
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):456-7. PubMed ID: 17302885
    [No Abstract]   [Full Text] [Related]  

  • 4. Rimonabant redux and strategies to improve the future outlook of CB1 receptor neutral-antagonist/inverse-agonist therapies.
    Ward SJ; Raffa RB
    Obesity (Silver Spring); 2011 Jul; 19(7):1325-34. PubMed ID: 21475141
    [No Abstract]   [Full Text] [Related]  

  • 5. The safety of obesity drugs.
    Van Gaal LF; Scheen AJ; Formiguera X
    Expert Opin Drug Saf; 2007 Sep; 6(5):475-6; author reply 477-8. PubMed ID: 17877434
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacology of cannabinoid receptors].
    Le Fur G; Rinaldi-Carmona M; Barth F; Alexander J
    Bull Acad Natl Med; 2007; 191(4-5):933-8; discussion 938-40. PubMed ID: 18225447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rimonabant: obituary for a wonder drug.
    Boekholdt SM; Peters RJ
    Lancet; 2010 Aug; 376(9740):489-90. PubMed ID: 20709215
    [No Abstract]   [Full Text] [Related]  

  • 8. [The potential use of cannabidiol in the therapy of metabolic syndrome].
    Kleiner D; Ditrói K
    Orv Hetil; 2012 Apr; 153(13):499-504. PubMed ID: 22430005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of rimonabant on weight reduction and cardiovascular risk.
    Hirschel B
    Lancet; 2005 Jul 30-Aug 5; 366(9483):369; author reply 369-70. PubMed ID: 16054934
    [No Abstract]   [Full Text] [Related]  

  • 10. [Endocannabinoid and endocannabinoid receptor antagonists].
    Heinzl S
    Med Monatsschr Pharm; 2005 Feb; 28(2):40-3. PubMed ID: 15727333
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rimonabant induces partial seizures in a patient with a history of generalized epilepsy.
    Braakman HM; van Oostenbrugge RJ; van Kranen-Mastenbroek VH; de Krom MC
    Epilepsia; 2009 Sep; 50(9):2171-2. PubMed ID: 19706063
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacotherapy for obesity--promise and uncertainty.
    Yanovski SZ
    N Engl J Med; 2005 Nov; 353(20):2187-9. PubMed ID: 16291989
    [No Abstract]   [Full Text] [Related]  

  • 14. [A drug for therapy of obesity: really only life style? (interview by Dirk Einecke)].
    Wirth A
    MMW Fortschr Med; 2006 Nov; 148(46):17. PubMed ID: 17615781
    [No Abstract]   [Full Text] [Related]  

  • 15. Impairments in endocannabinoid signaling and depressive illness.
    Hill MN; Gorzalka BB
    JAMA; 2009 Mar; 301(11):1165-6. PubMed ID: 19293417
    [No Abstract]   [Full Text] [Related]  

  • 16. New diet drug stirs high hopes. But can the pill, rimonabant, liver up to large expectations?
    Heart Advis; 2005 Feb; 8(2):3. PubMed ID: 15806687
    [No Abstract]   [Full Text] [Related]  

  • 17. [Still questions around the slimming agent rimobant. Not approved in USA because of the risk of mental adverse effects].
    Wettermark B; Raaschou P; Forslund T; Hjemdahl P
    Lakartidningen; 2007 Dec; 104(51-52):3879-81. PubMed ID: 18232530
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological concepts for the treatment of obesity - a therapeutic meander?].
    Schindler C; Chavakis T; Lamounier-Zepter V; Bornstein SR
    Dtsch Med Wochenschr; 2011 Aug; 136(31-32):1570-3. PubMed ID: 21809243
    [No Abstract]   [Full Text] [Related]  

  • 19. The cardiometabolic drug rimonabant: after 2 years of RIO-Europe and STRADIVARIUS.
    Kintscher U
    Eur Heart J; 2008 Jul; 29(14):1709-10. PubMed ID: 18556715
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety of obesity drugs.
    Greenway FL; Caruso MK
    Expert Opin Drug Saf; 2005 Nov; 4(6):1083-95. PubMed ID: 16255666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.